Lucid Diagnostics Inc. (LUCD) Stock Forecast
Data as of Jul 31, 2026Healthcare · Current price $0.87 (-3.41%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 13, 2024 | Mike Matson | Needham | $2.50 | +187.2% |
| May 14, 2024 | Kyle Mikson | Canaccord Genuity | $3.00 | +244.6% |
| Apr 8, 2024 | Mark Massaro | BTIG | $2.50 | +187.2% |
Top Analysts Covering LUCD
LUCD vs Sector & Market
| Metric | LUCD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 6 | 8 | 19 |
| Target Upside | +120.2% | +16366.0% | +18.0% |
| P/E Ratio | -1.83 | 3.01 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $3M | $3M | $3M | 1 |
| 2026-12-31 | $4M | $4M | $4M | 2 |
| 2027-03-31 | $4M | $4M | $4M | 1 |
| 2027-06-30 | $5M | $5M | $6M | 2 |
| 2027-09-30 | $6M | $7M | $8M | 2 |
| 2027-12-31 | $8M | $9M | $9M | 1 |
| 2028-12-31 | $23M | $29M | $38M | 1 |
| 2029-12-31 | $34M | $42M | $56M | 1 |
| 2030-12-31 | $48M | $59M | $78M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $-0.06 | $-0.06 | $-0.05 | 1 |
| 2026-12-31 | $-0.06 | $-0.06 | $-0.05 | 1 |
| 2027-03-31 | $-0.06 | $-0.06 | $-0.05 | 1 |
| 2027-06-30 | $-0.06 | $-0.05 | $-0.04 | 1 |
| 2027-09-30 | $-0.05 | $-0.04 | $-0.04 | 1 |
| 2027-12-31 | $-0.04 | $-0.04 | $-0.04 | 1 |
| 2028-12-31 | $-0.23 | $-0.16 | $-0.12 | 1 |
| 2029-12-31 | $-0.19 | $-0.13 | $-0.10 | 1 |
| 2030-12-31 | $-0.13 | $-0.09 | $-0.07 | 1 |
Frequently Asked Questions
What is the analyst consensus for LUCD?
The consensus among 6 analysts covering Lucid Diagnostics Inc. (LUCD) is Buy with an average price target of $2.00.
What is the highest price target for LUCD?
The highest price target for LUCD is $3.00, set by Kyle Mikson at Canaccord Genuity on 2024-05-14.
What is the lowest price target for LUCD?
The lowest price target for LUCD is $2.50, set by Mark Massaro at BTIG on 2024-04-08.
How many analysts cover LUCD?
6 analysts have issued ratings for Lucid Diagnostics Inc. in the past 12 months.
Is LUCD a buy or sell right now?
Based on 6 analyst ratings, LUCD has a consensus rating of Buy (2.00/5) with a +120.2% upside to the consensus target of $2.00.
What are the earnings estimates for LUCD?
Analysts estimate LUCD will report EPS of $-0.06 for the period ending 2026-09-30, with revenue estimated at $3M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.